NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.150
-0.060 (-2.71%)
At close: Apr 28, 2026, 4:00 PM EDT
2.128
-0.022 (-1.01%)
After-hours: Apr 28, 2026, 6:45 PM EDT
NuCana Employees
As of December 31, 2025, NuCana had 12 total employees, including 10 full-time and 2 part-time employees. The number of employees decreased by 10 or -45.45% compared to the previous year.
Employees
12
Change (1Y)
-10
Growth (1Y)
-45.45%
Revenue / Employee
n/a
Profits / Employee
-$3,292,171
Market Cap
8.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Bolt Biotherapeutics | 23 |
| CalciMedica | 16 |
| Genprex | 13 |
| Kiora Pharmaceuticals | 13 |
| Aprea Therapeutics | 8 |
| Enveric Biosciences | 6 |
| Quoin Pharmaceuticals | 5 |
NCNA News
- 5 weeks ago - NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - NuCana Appoints Theresa Bruce as Chief Operating Officer - GlobeNewsWire
- 4 months ago - NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma - GlobeNewsWire
- 5 months ago - NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China - GlobeNewsWire
- 8 months ago - NuCana Compliant with All Nasdaq Continued Listing Criteria - GlobeNewsWire
- 8 months ago - NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025 - GlobeNewsWire
- 8 months ago - NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire